Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV

Pfizer

Status: Completed

Conditions: Serious Fungal Infections

Treatments: Drug: voriconazole IV

Study type: Observational

Funder types: Industry

Identifiers

NCT01073618

A1501067

Details and patient eligibility

About

This is non-interventional study of voriconazole IV formulation in clinical use, which was mandated by the Korean government agency following the approval of Vfend in the Republic of Korea.

Enrollment: 692 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Invasive aspergillosis and other serious fungal infections.

Exclusion criteria

• N/A

Trial design

692 participants in 1 patient group

A.

Description:

Patients who are indicated for VFEND according to drug package insert.

Treatment:

Drug: voriconazole IV